MAPT and Alzheimer disease: In AD, the ubiquitin–proteasome system (UPS) removes soluble tau proteins through TRAF6 (tumor necrosis factor receptor-associated factor 6)-mediated tau polyubiquitination, resulting in degradation through the proteasome or autophagy pathway.